{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T04:11:07Z","timestamp":1769746267526,"version":"3.49.0"},"reference-count":164,"publisher":"Bentham Science Publishers Ltd.","issue":"38","funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31870937"],"award-info":[{"award-number":["31870937"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["2020JJ4076"],"award-info":[{"award-number":["2020JJ4076"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013254","name":"National Training Program of Innovation and Entrepreneurship for Undergraduates","doi-asserted-by":"publisher","award":["202210555075"],"award-info":[{"award-number":["202210555075"]}],"id":[{"id":"10.13039\/501100013254","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMC"],"published-print":{"date-parts":[[2023,11]]},"abstract":"<jats:sec>\n<jats:title>Abstract:<\/jats:title>\n<jats:p>Atherosclerosis (AS) is the major factor of cardiovascular disease (CVD) and\nis characterized by a progressive and chronic inflammatory process in the arterial wall.\nRecent studies have shown that disruption of the mitochondrial membrane potential\n(deltapsi (m)) directly affects the electron transport chain (ETC), which in turn\nleads to oxidative stress, and furthermore, its alteration leads to apoptosis and activation\nof the NLRP3 inflammasome, thereby promoting the development of AS. Here, this review\ndescribes how deltapsi (m) contributes to the development of AS by mediating\noxidative stress, apoptosis, and NLRP3 inflammasome activation, and potential AS intervention\nstrategies by targeting oxidative stress, apoptosis, and NLRP3 inflammasome activation\ninduced by deltapsi (m).<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0929867330666221201120405","type":"journal-article","created":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T04:11:26Z","timestamp":1670213486000},"page":"4355-4373","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Atherosclerosis: From the Disruption of Mitochondrial Membrane\nPotential to the Potential Interventional Strategies"],"prefix":"10.2174","volume":"30","author":[{"given":"Dexiang","family":"Xia","sequence":"first","affiliation":[{"name":"Institute of Cardiovascular Disease, Key Laboratory for Arteriosclerology of Hunan Province, Hunan International\nScientific and Technological Cooperation Base of Arteriosclerotic Disease, Hengyang Medical\nSchool, University of South China, Hengyang, Hunan 421001, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanmei","family":"Chen","sequence":"additional","affiliation":[{"name":"Institute of Cardiovascular Disease, Key Laboratory for Arteriosclerology of Hunan Province, Hunan International\nScientific and Technological Cooperation Base of Arteriosclerotic Disease, Hengyang Medical\nSchool, University of South China, Hengyang, Hunan 421001, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guifang","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Gynecology, The\nFirst Affiliated Hospital of University of South China, Hengyang, 421001, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dangheng","family":"Wei","sequence":"additional","affiliation":[{"name":"Institute of Cardiovascular Disease, Key Laboratory for Arteriosclerology of Hunan Province, Hunan International\nScientific and Technological Cooperation Base of Arteriosclerotic Disease, Hengyang Medical\nSchool, University of South China, Hengyang, Hunan 421001, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","volume":"76","author":"Roth G.A.","year":"2020","unstructured":"Roth G.A.; Mensah G.A.; Johnson C.O.; Addolorato G.; Ammirati E.; Baddour L.M.; Barengo N.C.; Beaton A.Z.; Benjamin E.J.; Benziger C.P.; Bonny A.; Brauer M.; Brodmann M.; Cahill T.J.; Carapetis J.; Catapano A.L.; Chugh S.S.; Cooper L.T.; Coresh J.; Criqui M.; DeCleene N.; Eagle K.A.; Emmons-Bell S.; Feigin V.L.; Fern\u00e1ndez-Sol\u00e0 J.; Fowkes G.; Gakidou E.; Grundy S.M.; He F.J.; Howard G.; Hu F.; Inker L.; Karthikeyan G.; Kassebaum N.; Koroshetz W.; Lavie C.; Lloyd-Jones D.; Lu H.S.; Mirijello A.; Temesgen A.M.; Mokdad A.; Moran A.E.; Muntner P.; Narula J.; Neal B.; Ntsekhe M.; Moraes de Oliveira G.; Otto C.; Owolabi M.; Pratt M.; Rajagopalan S.; Reitsma M.; Ribeiro A.L.P.; Rigotti N.; Rodgers A.; Sable C.; Shakil S.; Sliwa-Hahnle K.; Stark B.; Sundstr\u00f6m J.; Timpel P.; Tleyjeh I.M.; Valgimigli M.; Vos T.; Whelton P.K.; Yacoub M.; Zuhlke L.; Murray C.; Fuster V.; Roth G.A.; Mensah G.A.; Johnson C.O.; Addolorato G.; Ammirati E.; Baddour L.M.; Barengo N.C.; Beaton A.; Benjamin E.J.; Benziger C.P.; Bonny A.; Brauer M.; Brodmann M.; Cahill T.J.; Carapetis J.R.; Catapano A.L.; Chugh S.; Cooper L.T.; Coresh J.; Criqui M.H.; DeCleene N.K.; Eagle K.A.; Emmons-Bell S.; Feigin V.L.; Fern\u00e1ndez-Sola J.; Fowkes F.G.R.; Gakidou E.; Grundy S.M.; He F.J.; Howard G.; Hu F.; Inker L.; Karthikeyan G.; Kassebaum N.J.; Koroshetz W.J.; Lavie C.; Lloyd-Jones D.; Lu H.S.; Mirijello A.; Misganaw A.T.; Mokdad A.H.; Moran A.E.; Muntner P.; Narula J.; Neal B.; Ntsekhe M.; Oliveira G.M.M.; Otto C.M.; Owolabi M.O.; Pratt M.; Rajagopalan S.; Reitsma M.B.; Ribeiro A.L.P.; Rigotti N.A.; Rodgers A.; Sable C.A.; Shakil S.S.; Sliwa K.; Stark B.A.; Sundstr\u00f6m J.; Timpel P.; Tleyjeh I.I.; Valgimigli M.; Vos T.; Whelton P.K.; Yacoub M.; Zuhlke L.J.; Abbasi-Kangevari M.; Abdi A.; Abedi A.; Aboyans V.; Abrha W.A.; Abu-Gharbieh E.; Abushouk A.I.; Acharya D.; Adair T.; Adebayo O.M.; Ademi Z.; Advani S.M.; Afshari K.; Afshin A.; Agarwal G.; Agasthi P.; Ahmad S.; Ahmadi S.; Ahmed M.B.; Aji B.; Akalu Y.; Akande-Sholabi W.; Aklilu A.; Akunna C.J.; Alahdab F.; Al-Eyadhy A.; Alhabib K.F.; Alif S.M.; Alipour V.; Aljunid S.M.; Alla F.; Almasi-Hashiani A.; Almustanyir S.; Al-Raddadi R.M.; Amegah A.K.; Amini S.; Aminorroaya A.; Amu H.; Amugsi D.A.; Ancuceanu R.; Anderlini D.; Andrei T.; Andrei C.L.; Ansari-Moghaddam A.; Anteneh Z.A.; Antonazzo I.C.; Antony B.; Anwer R.; Appiah L.T.; Arabloo J.; \u00c4rnl\u00f6v J.; Artanti K.D.; Ataro Z.; Ausloos M.; Avila-Burgos L.; Awan A.T.; Awoke M.A.; Ayele H.T.; Ayza M.A.; Azari S.; B D.B.; Baheiraei N.; Baig A.A.; Bakhtiari A.; Banach M.; Banik P.C.; Baptista E.A.; Barboza M.A.; Barua L.; Basu S.; Bedi N.; B\u00e9jot Y.; Bennett D.A.; Bensenor I.M.; Berman A.E.; Bezabih Y.M.; Bhagavathula A.S.; Bhaskar S.; Bhattacharyya K.; Bijani A.; Bikbov B.; Birhanu M.M.; Boloor A.; Brant L.C.; Brenner H.; Briko N.I.; Butt Z.A.; Caetano dos Santos F.L.; Cahill L.E.; Cahuana-Hurtado L.; C\u00e1mera L.A.; Campos-Nonato I.R.; Cantu-Brito C.; Car J.; Carrero J.J.; Carvalho F.; Casta\u00f1eda-Orjuela C.A.; Catal\u00e1-L\u00f3pez F.; Cerin E.; Charan J.; Chattu V.K.; Chen S.; Chin K.L.; Choi J-Y.J.; Chu D-T.; Chung S-C.; Cirillo M.; Coffey S.; Conti S.; Costa V.M.; Cundiff D.K.; Dadras O.; Dagnew B.; Dai X.; Damasceno A.A.M.; Dandona L.; Dandona R.; Davletov K.; De la Cruz-G\u00f3ngora V.; De la Hoz F.P.; De Neve J-W.; Denova-Guti\u00e9rrez E.; Derbew Molla M.; Derseh B.T.; Desai R.; Deuschl G.; Dharmaratne S.D.; Dhimal M.; Dhungana R.R.; Dianatinasab M.; Diaz D.; Djalalinia S.; Dokova K.; Douiri A.; Duncan B.B.; Duraes A.R.; Eagan A.W.; Ebtehaj S.; Eftekhari A.; Eftekharzadeh S.; Ekholuenetale M.; El Nahas N.; Elgendy I.Y.; Elhadi M.; El-Jaafary S.I.; Esteghamati S.; Etisso A.E.; Eyawo O.; Fadhil I.; Faraon E.J.A.; Faris P.S.; Farwati M.; Farzadfar F.; Fernandes E.; Fernandez Prendes C.; Ferrara P.; Filip I.; Fischer F.; Flood D.; Fukumoto T.; Gad M.M.; Gaidhane S.; Ganji M.; Garg J.; Gebre A.K.; Gebregiorgis B.G.; Gebregzabiher K.Z.; Gebremeskel G.G.; Getacher L.; Obsa A.G.; Ghajar A.; Ghashghaee A.; Ghith N.; Giampaoli S.; Gilani S.A.; Gill P.S.; Gillum R.F.; Glushkova E.V.; Gnedovskaya E.V.; Golechha M.; Gonfa K.B.; Goudarzian A.H.; Goulart A.C.; Guadamuz J.S.; Guha A.; Guo Y.; Gupta R.; Hachinski V.; Hafezi-Nejad N.; Haile T.G.; Hamadeh R.R.; Hamidi S.; Hankey G.J.; Hargono A.; Hartono R.K.; Hashemian M.; Hashi A.; Hassan S.; Hassen H.Y.; Havmoeller R.J.; Hay S.I.; Hayat K.; Heidari G.; Herteliu C.; Holla R.; Hosseini M.; Hosseinzadeh M.; Hostiuc M.; Hostiuc S.; Househ M.; Huang J.; Humayun A.; Iavicoli I.; Ibeneme C.U.; Ibitoye S.E.; Ilesanmi O.S.; Ilic I.M.; Ilic M.D.; Iqbal U.; Irvani S.S.N.; Islam S.M.S.; Islam R.M.; Iso H.; Iwagami M.; Jain V.; Javaheri T.; Jayapal S.K.; Jayaram S.; Jayawardena R.; Jeemon P.; Jha R.P.; Jonas J.B.; Jonnagaddala J.; Joukar F.; Jozwiak J.J.; J\u00fcrisson M.; Kabir A.; Kahlon T.; Kalani R.; Kalhor R.; Kamath A.; Kamel I.; Kandel H.; Kandel A.; Karch A.; Kasa A.S.; Katoto P.D.M.C.; Kayode G.A.; Khader Y.S.; Khammarnia M.; Khan M.S.; Khan M.N.; Khan M.; Khan E.A.; Khatab K.; Kibria G.M.A.; Kim Y.J.; Kim G.R.; Kimokoti R.W.; Kisa S.; Kisa A.; Kivim\u00e4ki M.; Kolte D.; Koolivand A.; Korshunov V.A.; Koulmane Laxminarayana S.L.; Koyanagi A.; Krishan K.; Krishnamoorthy V.; Kuate Defo B.; Kucuk Bicer B.; Kulkarni V.; Kumar G.A.; Kumar N.; Kurmi O.P.; Kusuma D.; Kwan G.F.; La Vecchia C.; Lacey B.; Lallukka T.; Lan Q.; Lasrado S.; Lassi Z.S.; Lauriola P.; Lawrence W.R.; Laxmaiah A.; LeGrand K.E.; Li M-C.; Li B.; Li S.; Lim S.S.; Lim L-L.; Lin H.; Lin Z.; Lin R-T.; Liu X.; Lopez A.D.; Lorkowski S.; Lotufo P.A.; Lugo A.; M N.K.; Madotto F.; Mahmoudi M.; Majeed A.; Malekzadeh R.; Malik A.A.; Mamun A.A.; Manafi N.; Mansournia M.A.; Mantovani L.G.; Martini S.; Mathur M.R.; Mazzaglia G.; Mehata S.; Mehndiratta M.M.; Meier T.; Menezes R.G.; Meretoja A.; Mestrovic T.; Miazgowski B.; Miazgowski T.; Michalek I.M.; Miller T.R.; Mirrakhimov E.M.; Mirzaei H.; Moazen B.; Moghadaszadeh M.; Mohammad Y.; Mohammad D.K.; Mohammed S.; Mohammed M.A.; Mokhayeri Y.; Molokhia M.; Montasir A.A.; Moradi G.; Moradzadeh R.; Moraga P.; Morawska L.; Moreno Vel\u00e1squez I.; Morze J.; Mubarik S.; Muruet W.; Musa K.I.; Nagarajan A.J.; Nalini M.; Nangia V.; Naqvi A.A.; Narasimha Swamy S.; Nascimento B.R.; Nayak V.C.; Nazari J.; Nazarzadeh M.; Negoi R.I.; Neupane Kandel S.; Nguyen H.L.T.; Nixon M.R.; Norrving B.; Noubiap J.J.; Nouthe B.E.; Nowak C.; Odukoya O.O.; Ogbo F.A.; Olagunju A.T.; Orru H.; Ortiz A.; Ostroff S.M.; Padubidri J.R.; Palladino R.; Pana A.; Panda-Jonas S.; Parekh U.; Park E-C.; Parvizi M.; Pashazadeh Kan F.; Patel U.K.; Pathak M.; Paudel R.; Pepito V.C.F.; Perianayagam A.; Perico N.; Pham H.Q.; Pilgrim T.; Piradov M.A.; Pishgar F.; Podder V.; Polibin R.V.; Pourshams A.; Pribadi D.R.A.; Rabiee N.; Rabiee M.; Radfar A.; Rafiei A.; Rahim F.; Rahimi-Movaghar V.; Ur Rahman M.H.; Rahman M.A.; Rahmani A.M.; Rakovac I.; Ram P.; Ramalingam S.; Rana J.; Ranasinghe P.; Rao S.J.; Rathi P.; Rawal L.; Rawasia W.F.; Rawassizadeh R.; Remuzzi G.; Renzaho A.M.N.; Rezapour A.; Riahi S.M.; Roberts-Thomson R.L.; Roever L.; Rohloff P.; Romoli M.; Roshandel G.; Rwegerera G.M.; Saadatagah S.; Saber-Ayad M.M.; Sabour S.; Sacco S.; Sadeghi M.; Saeedi Moghaddam S.; Safari S.; Sahebkar A.; Salehi S.; Salimzadeh H.; Samaei M.; Samy A.M.; Santos I.S.; Santric-Milicevic M.M.; Sarrafzadegan N.; Sarveazad A.; Sathish T.; Sawhney M.; Saylan M.; Schmidt M.I.; Schutte A.E.; Senthilkumaran S.; Sepanlou S.G.; Sha F.; Shahabi S.; Shahid I.; Shaikh M.A.; Shamali M.; Shamsizadeh M.; Shawon M.S.R.; Sheikh A.; Shigematsu M.; Shin M-J.; Shin J.I.; Shiri R.; Shiue I.; Shuval K.; Siabani S.; Siddiqi T.J.; Silva D.A.S.; Singh J.A.; Mtech A.S.; Skryabin V.Y.; Skryabina A.A.; Soheili A.; Spurlock E.E.; Stockfelt L.; Stortecky S.; Stranges S.; Suliankatchi Abdulkader R.; Tadbiri H.; Tadesse E.G.; Tadesse D.B.; Tajdini M.; Tariqujjaman M.; Teklehaimanot B.F.; Temsah M-H.; Tesema A.K.; Thakur B.; Thankappan K.R.; Thapar R.; Thrift A.G.; Timalsina B.; Tonelli M.; Touvier M.; Tovani-Palone M.R.; Tripathi A.; Tripathy J.P.; Truelsen T.C.; Tsegay G.M.; Tsegaye G.W.; Tsilimparis N.; Tusa B.S.; Tyrovolas S.; Umapathi K.K.; Unim B.; Unnikrishnan B.; Usman M.S.; Vaduganathan M.; Valdez P.R.; Vasankari T.J.; Velazquez D.Z.; Venketasubramanian N.; Vu G.T.; Vujcic I.S.; Waheed Y.; Wang Y.; Wang F.; Wei J.; Weintraub R.G.; Weldemariam A.H.; Westerman R.; Winkler A.S.; Wiysonge C.S.; Wolfe C.D.A.; Wubishet B.L.; Xu G.; Yadollahpour A.; Yamagishi K.; Yan L.L.; Yandrapalli S.; Yano Y.; Yatsuya H.; Yeheyis T.Y.; Yeshaw Y.; Yilgwan C.S.; Yonemoto N.; Yu C.; Yusefzadeh H.; Zachariah G.; Zaman S.B.; Zaman M.S.; Zamanian M.; Zand R.; Zandifar A.; Zarghi A.; Zastrozhin M.S.; Zastrozhina A.; Zhang Z-J.; Zhang Y.; Zhang W.; Zhong C.; Zou Z.; Zuniga Y.M.H.; Murray C.J.L.; Fuster V.; Global burden of cardiovascular diseases and risk factors, 1990\u20132019. J Am Coll Cardiol 2020,76(25),2982-3021","journal-title":"J Am Coll Cardiol"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"cvab309","DOI":"10.1093\/cvr\/cvab309","volume":"117","author":"Fredman G.","year":"2021","unstructured":"Fredman G.; MacNamara K.C.; Atherosclerosis is a major human killer and non-resolving inflammation is a prime suspect. Cardiovasc Res 2021,117(13),cvab309","journal-title":"Cardiovasc Res"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/s41573-021-00198-1","volume":"20","author":"Soehnlein O.","year":"2021","unstructured":"Soehnlein O.; Libby P.; Targeting inflammation in atherosclerosis \u2014 from experimental insights to the clinic. Nat Rev Drug Discov 2021,20(8),589-610","journal-title":"Nat Rev Drug Discov"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1161\/CIRCRESAHA.114.302721","volume":"114","author":"Bentzon J.F.","year":"2014","unstructured":"Bentzon J.F.; Otsuka F.; Virmani R.; Falk E.; Mechanisms of plaque formation and rupture. Circ Res 2014,114(12),1852-1866","journal-title":"Circ Res"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"482","DOI":"10.3390\/ijms23010482","volume":"23","author":"Zorova L.D.","year":"2022","unstructured":"Zorova L.D.; Demchenko E.A.; Korshunova G.A.; Tashlitsky V.N.; Zorov S.D.; Andrianova N.V.; Popkov V.A.; Babenko V.A.; Pevzner I.B.; Silachev D.N.; Plotnikov E.Y.; Zorov D.B.; Is the mitochondrial membrane potential (\u2206\u03a8) correctly assessed? intracellular and intramitochondrial modifications of the \u2206\u03a8 Probe, Rhodamine 123. Int J Mol Sci 2022,23(1),482","journal-title":"Int J Mol Sci"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"e3128","DOI":"10.21769\/BioProtoc.3128","volume":"9","author":"Sivandzade F.","year":"2019","unstructured":"Sivandzade F.; Bhalerao A.; Cucullo L.; Analysis of the mitochondrial membrane potential using the cationic JC-1 dye as a sensitive fluorescent probe. Bio Protoc 2019,9(1),e3128","journal-title":"Bio Protoc"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"9530007","DOI":"10.1155\/2022\/9530007","volume":"2022","author":"Stamerra C.A.","year":"2022","unstructured":"Stamerra C.A.; Di Giosia P.; Giorgini P.; Ferri C.; Sukhorukov V.N.; Sahebkar A.; Mitochondrial dysfunction and cardiovascular disease: Pathophysiology and emerging therapies. Oxid Med Cell Longev 2022,2022,9530007","journal-title":"Oxid Med Cell Longev"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1002\/med.21732","volume":"41","author":"Manolis A.S.","year":"2021","unstructured":"Manolis A.S.; Manolis A.A.; Manolis T.A.; Apostolaki N.E.; Apostolopoulos E.J.; Melita H.; Katsiki N.; Mitochondrial dysfunction in cardiovascular disease: Current status of translational research\/clinical and therapeutic implications. Med Res Rev 2021,41(1),275-313","journal-title":"Med Res Rev"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1080\/07853890.2017.1417631","volume":"50","author":"Chistiakov D.A.","year":"2018","unstructured":"Chistiakov D.A.; Shkurat T.P.; Melnichenko A.A.; Grechko A.V.; Orekhov A.N.; The role of mitochondrial dysfunction in cardiovascular disease: A brief review. Ann Med 2018,50(2),121-127","journal-title":"Ann Med"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"4924","DOI":"10.3390\/ijms20194924","volume":"20","author":"Lee J.H.","year":"2019","unstructured":"Lee J.H.; Park A.; Oh K.J.; Lee S.C.; Kim W.K.; Bae K.H.; The role of adipose tissue mitochondria: Regulation of mitochondrial function for the treatment of metabolic diseases. Int J Mol Sci 2019,20(19),4924","journal-title":"Int J Mol Sci"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"165838","DOI":"10.1016\/j.bbadis.2020.165838","volume":"1866","author":"Prasun P.","year":"2020","unstructured":"Prasun P.; Mitochondrial dysfunction in metabolic syndrome. Biochim Biophys Acta Mol Basis Dis 2020,1866(10),165838","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"108698","DOI":"10.1016\/j.abb.2020.108698","volume":"702","author":"Johnson J.","year":"2021","unstructured":"Johnson J.; Mercado-Ayon E.; Mercado-Ayon Y.; Dong Y.N.; Halawani S.; Ngaba L.; Lynch D.R.; Mitochondrial dysfunction in the development and progression of neurodegenerative diseases. Arch Biochem Biophys 2021,702,108698","journal-title":"Arch Biochem Biophys"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1111\/cns.13116","volume":"25","author":"Wang Y.","year":"2019","unstructured":"Wang Y.; Xu E.; Musich P.R.; Lin F.; Mitochondrial dysfunction in neurodegenerative diseases and the potential countermeasure. CNS Neurosci Ther 2019,25(7),816-824","journal-title":"CNS Neurosci Ther"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"4850","DOI":"10.3390\/ijms22094850","volume":"22","author":"Sharma C.","year":"2021","unstructured":"Sharma C.; Kim S.; Nam Y.; Jung U.J.; Kim S.R.; Mitochondrial dysfunction as a driver of cognitive impairment in Alzheimer\u2019s disease. Int J Mol Sci 2021,22(9),4850","journal-title":"Int J Mol Sci"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1038\/s41586-019-1715-0","volume":"575","author":"Momcilovic M.","year":"2019","unstructured":"Momcilovic M.; Jones A.; Bailey S.T.; Waldmann C.M.; Li R.; Lee J.T.; Abdelhady G.; Gomez A.; Holloway T.; Schmid E.; Stout D.; Fishbein M.C.; Stiles L.; Dabir D.V.; Dubinett S.M.; Christofk H.; Shirihai O.; Koehler C.M.; Sadeghi S.; Shackelford D.B.; In vivo imaging of mitochondrial membrane potential in non-small-cell lung cancer. Nature 2019,575(7782),380-384","journal-title":"Nature"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"5598","DOI":"10.3390\/ijms21165598","volume":"21","author":"Luo Y.","year":"2020","unstructured":"Luo Y.; Ma J.; Lu W.; The significance of mitochondrial dysfunction in cancer. Int J Mol Sci 2020,21(16),5598","journal-title":"Int J Mol Sci"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1089\/ars.2019.7898","volume":"32","author":"Chiu H.Y.","year":"2020","unstructured":"Chiu H.Y.; Tay E.X.Y.; Ong D.S.T.; Taneja R.; Mitochondrial dysfunction at the center of cancer therapy. Antioxid Redox Signal 2020,32(5),309-330","journal-title":"Antioxid Redox Signal"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1124\/jpet.119.257725","volume":"370","author":"Ramzan R.","year":"2019","unstructured":"Ramzan R.; Michels S.; Weber P.; Rhiel A.; Irqsusi M.; Rastan A.J.; Culmsee C.; Vogt S.; Protamine sulfate induces mitochondrial hyperpolarization and a subsequent increase in reactive oxygen species production. J Pharmacol Exp Ther 2019,370(2),308-317","journal-title":"J Pharmacol Exp Ther"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.chemosphere.2018.06.075","volume":"209","author":"Pereira A.G.","year":"2018","unstructured":"Pereira A.G.; Jaramillo M.L.; Remor A.P.; Latini A.; Davico C.E.; da Silva M.L.; M\u00fcller Y.M.R.; Ammar D.; Nazari E.M.; Low-concentration exposure to glyphosate-based herbicide modulates the complexes of the mitochondrial respiratory chain and induces mitochondrial hyperpolarization in the Danio rerio brain. Chemosphere 2018,209,353-362","journal-title":"Chemosphere"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.18632\/aging.101910","volume":"11","author":"Huang Y.","year":"2019","unstructured":"Huang Y.; Zhu X.; Chen K.; Lang H.; Zhang Y.; Hou P.; Ran L.; Zhou M.; Zheng J.; Yi L.; Mi M.; Zhang Q.; Resveratrol prevents sarcopenic obesity by reversing mitochondrial dysfunction and oxidative stress via the PKA\/LKB1\/AMPK pathway. Aging 2019,11(8),2217-2240","journal-title":"Aging"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"112283","DOI":"10.1016\/j.fct.2021.112283","volume":"153","author":"Cong L.","year":"2021","unstructured":"Cong L.; Lei M.Y.; Liu Z.Q.; Liu Z.F.; Ma Z.; Liu K.; Li J.; Deng Y.; Liu W.; Xu B.; Resveratrol attenuates manganese-induced oxidative stress and neuroinflammation through SIRT1 signaling in mice. Food Chem Toxicol 2021,153,112283","journal-title":"Food Chem Toxicol"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3390\/molecules26010229","volume":"26","author":"Meng T.","year":"2021","unstructured":"Meng T.; Xiao D.; Muhammed A.; Deng J.; Chen L.; He J.; Anti-inflammatory action and mechanisms of resveratrol. Molecules 2021,26(1),229","journal-title":"Molecules"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.canlet.2021.05.001","volume":"515","author":"Ren B.","year":"2021","unstructured":"Ren B.; Kwah M.X.Y.; Liu C.; Ma Z.; Shanmugam M.K.; Ding L.; Xiang X.; Ho P.C.L.; Wang L.; Ong P.S.; Goh B.C.; Resveratrol for cancer therapy: Challenges and future perspectives. Cancer Lett 2021,515,63-72","journal-title":"Cancer Lett"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"925","DOI":"10.3390\/ijms20040925","volume":"20","author":"Han Y.","year":"2019","unstructured":"Han Y.; Jo H.; Cho J.; Dhanasekaran D.; Song Y.; Resveratrol as a tumor-suppressive nutraceutical modulating tumor microenvironment and malignant behaviors of cancer. Int J Mol Sci 2019,20(4),925","journal-title":"Int J Mol Sci"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"10152","DOI":"10.3390\/ijms221810152","volume":"22","author":"Gal R.","year":"2021","unstructured":"Gal R.; Deres L.; Toth K.; Halmosi R.; Habon T.; The effect of resveratrol on the cardiovascular system from molecular mechanisms to clinical results. Int J Mol Sci 2021,22(18),10152","journal-title":"Int J Mol Sci"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1111\/bph.14801","volume":"177","author":"Cheng C.K.","year":"2020","unstructured":"Cheng C.K.; Luo J.Y.; Lau C.W.; Chen Z.Y.; Tian X.Y.; Huang Y.; Pharmacological basis and new insights of resveratrol action in the cardiovascular system. Br J Pharmacol 2020,177(6),1258-1277","journal-title":"Br J Pharmacol"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1016\/j.fertnstert.2020.08.016","volume":"115","author":"Ragonese F.","year":"2021","unstructured":"Ragonese F.; Monarca L.; De Luca A.; Mancinelli L.; Mariani M.; Corbucci C.; Gerli S.; Iannitti R.G.; Leonardi L.; Fioretti B.; Resveratrol depolarizes the membrane potential in human granulosa cells and promotes mitochondrial biogenesis. Fertil Steril 2021,115(4),1063-1073","journal-title":"Fertil Steril"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"e91308","DOI":"10.1371\/journal.pone.0091308","volume":"9","author":"Zhong Z.","year":"2014","unstructured":"Zhong Z.; Ramshesh V.K.; Rehman H.; Liu Q.; Theruvath T.P.; Krishnasamy Y.; Lemasters J.J.; Acute ethanol causes hepatic mitochondrial depolarization in mice: Role of ethanol metabolism. PLoS One 2014,9(3),e91308","journal-title":"PLoS One"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"102108","DOI":"10.1016\/j.ceca.2019.102108","volume":"84","author":"Zhang X.","year":"2019","unstructured":"Zhang X.; Lee M.D.; Wilson C.; McCarron J.G.; Hydrogen peroxide depolarizes mitochondria and inhibits IP-evoked Ca release in the endothelium of intact arteries. Cell Calcium 2019,84,102108","journal-title":"Cell Calcium"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3892\/ijmm.2019.4188","volume":"44","author":"Zhao R.Z.","year":"2019","unstructured":"Zhao R.Z.; Jiang S.; Zhang L.; Yu Z.B.; Mitochondrial electron transport chain, ROS generation and uncoupling. Int J Mol Med 2019,44(1),3-15","journal-title":"Int J Mol Med"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1152\/physrev.00026.2013","volume":"94","author":"Zorov D.B.","year":"2014","unstructured":"Zorov D.B.; Juhaszova M.; Sollott S.J.; Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release. Physiol Rev 2014,94(3),909-950","journal-title":"Physiol Rev"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1161\/01.ATV.15.10.1616","volume":"15","author":"Suarna C.","year":"1995","unstructured":"Suarna C.; Dean R.T.; May J.; Stocker R.; Human atherosclerotic plaque contains both oxidized lipids and relatively large amounts of alpha-tocopherol and ascorbate. Arterioscler Thromb Vasc Biol 1995,15(10),1616-1624","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"3236","DOI":"10.1161\/01.ATV.17.11.3236","volume":"17","author":"Gniwotta C.","year":"1997","unstructured":"Gniwotta C.; Morrow J.D.; Roberts L.J.; K\u00fchn H.; Prostaglandin F2-like compounds, F2-isoprostanes, are present in increased amounts in human atherosclerotic lesions. Arterioscler Thromb Vasc Biol 1997,17(11),3236-3241","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.bbrc.2004.12.152","volume":"328","author":"Luchtefeld M.","year":"2005","unstructured":"Luchtefeld M.; Grote K.; Grothusen C.; Bley S.; Bandlow N.; Selle T.; Str\u00fcber M.; Haverich A.; Bavendiek U.; Drexler H.; Schieffer B.; Angiotensin II induces MMP-2 in a p47phox-dependent manner. Biochem Biophys Res Commun 2005,328(1),183-188","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1016\/j.febslet.2008.02.080","volume":"582","author":"Donnini S.","year":"2008","unstructured":"Donnini S.; Monti M.; Roncone R.; Morbidelli L.; Rocchigiani M.; Oliviero S.; Casella L.; Giachetti A.; Schulz R.; Ziche M.; Peroxynitrite inactivates human-tissue inhibitor of metalloproteinase-4. FEBS Lett 2008,582(7),1135-1140","journal-title":"FEBS Lett"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"5245308","DOI":"10.1155\/2020\/5245308","volume":"2020","author":"Khatana C.","year":"2020","unstructured":"Khatana C.; Saini N.K.; Chakrabarti S.; Saini V.; Sharma A.; Saini R.V.; Saini A.K.; Mechanistic insights into the oxidized low-density lipoprotein-induced atherosclerosis. Oxid Med Cell Longev 2020,2020,5245308","journal-title":"Oxid Med Cell Longev"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/j.bbabio.2010.02.016","volume":"1797","author":"Aon M.A.","year":"2010","unstructured":"Aon M.A.; Cortassa S.; O\u2019Rourke B.; Redox-optimized ROS balance: A unifying hypothesis. Biochim Biophys Acta Bioenerg 2010,1797(6-7),865-877","journal-title":"Biochim Biophys Acta Bioenerg"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1042\/bj2170453","volume":"217","author":"Brand M.D.","year":"1984","unstructured":"Brand M.D.; Felber S.M.; Membrane potential of mitochondria in intact lymphocytes during early mitogenic stimulation. Biochem J 1984,217(2),453-459","journal-title":"Biochem J"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1006\/abio.2001.5348","volume":"298","author":"Zhang H.","year":"2001","unstructured":"Zhang H.; Huang H.M.; Carson R.C.; Mahmood J.; Thomas H.M.; Gibson G.E.; Assessment of membrane potentials of mitochondrial populations in living cells. Anal Biochem 2001,298(2),170-180","journal-title":"Anal Biochem"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"C178","DOI":"10.1152\/ajpcell.1993.265.1.C178","volume":"265","author":"Backus M.","year":"1993","unstructured":"Backus M.; Piwnica-Worms D.; Hockett D.; Kronauge J.; Lieberman M.; Ingram P.; LeFurgey A.; Microprobe analysis of Tc-MIBI in heart cells: Calculation of mitochondrial membrane potential. Am J Physiol Cell Physiol 1993,265(1),C178-C187","journal-title":"Am J Physiol Cell Physiol"},{"key":"ref=41","doi-asserted-by":"crossref","first-page":"H453","DOI":"10.1152\/ajpcell.1993.265.2.C453","volume":"265","author":"Wan B.","year":"1993","unstructured":"Wan B.; Doumen C.; Duszynski J.; Salama G.; Vary T.C.; LaNoue K.F.; Effects of cardiac work on electrical potential gradient across mitochondrial membrane in perfused rat hearts. Am J Physiol 1993,265(2 Pt 2),H453-H460","journal-title":"Am J Physiol"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/978-1-4939-7831-1_22","volume":"1782","author":"Suski J.","year":"2018","unstructured":"Suski J.; Lebiedzinska M.; Bonora M.; Pinton P.; Duszynski J.; Wieckowski M.R.; Relation between mitochondrial membrane potential and ROS formation. Methods Mol Biol 2018,1782,357-381","journal-title":"Methods Mol Biol"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"60","DOI":"10.3390\/biology9030060","volume":"9","author":"Poznyak A.V.","year":"2020","unstructured":"Poznyak A.V.; Grechko A.V.; Orekhova V.A.; Chegodaev Y.S.; Wu W.K.; Orekhov A.N.; Oxidative stress and antioxidants in atherosclerosis development and treatment. Biology 2020,9(3),60","journal-title":"Biology"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"301","DOI":"10.3390\/biom9080301","volume":"9","author":"Malekmohammad K.","year":"2019","unstructured":"Malekmohammad K.; Sewell R.D.E.; Rafieian-Kopaei M.; Antioxidants and atherosclerosis: Mechanistic aspects. Biomolecules 2019,9(8),301","journal-title":"Biomolecules"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"5032","DOI":"10.1002\/chem.201704561","volume":"24","author":"Bonetta R.","year":"2018","unstructured":"Bonetta R.; Potential therapeutic applications of MnSODs and SOD-mimetics. Chemistry 2018,24(20),5032-5041","journal-title":"Chemistry"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1089\/ars.2009.2876","volume":"13","author":"Batini\u0107-Haberle I.","year":"2010","unstructured":"Batini\u0107-Haberle I.; Rebou\u00e7as J.S.; Spasojevi\u0107 I.; Superoxide dismutase mimics: Chemistry, pharmacology, and therapeutic potential. Antioxid Redox Signal 2010,13(6),877-918","journal-title":"Antioxid Redox Signal"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/s41573-021-00233-1","volume":"20","author":"Forman H.J.","year":"2021","unstructured":"Forman H.J.; Zhang H.; Targeting oxidative stress in disease: Promise and limitations of antioxidant therapy. Nat Rev Drug Discov 2021,20(9),689-709","journal-title":"Nat Rev Drug Discov"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1042\/BCJ20160480","volume":"474","author":"Ribeiro T.P.","year":"2017","unstructured":"Ribeiro T.P.; Fonseca F.L.; de Carvalho M.D.C.; Godinho R.M.C.; de Almeida F.P.; Saint\u2019Pierre T.D.; Rey N.A.; Fernandes C.; Horn A.; Pereira M.D.; Metal-based superoxide dismutase and catalase mimics reduce oxidative stress biomarkers and extend life span of Saccharomyces cerevisiae. Biochem J 2017,474(2),301-315","journal-title":"Biochem J"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1021\/acs.inorgchem.6b02695","volume":"56","author":"Mathieu E.","year":"2017","unstructured":"Mathieu E.; Bernard A.S.; Delsuc N.; Qu\u00e9vrain E.; Gazzah G.; Lai B.; Chain F.; Langella P.; Bachelet M.; Masliah J.; Seksik P.; Policar C.; A cell-penetrant Manganese Superoxide Dismutase (MnSOD) mimic is able to complement MnSOD and exerts an antiinflammatory effect on cellular and animal models of inflammatory bowel diseases. Inorg Chem 2017,56(5),2545-2555","journal-title":"Inorg Chem"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.1039\/C9DT04619D","volume":"49","author":"Mathieu E.","year":"2020","unstructured":"Mathieu E.; Bernard A.S.; Ching H.Y.V.; Somogyi A.; Medjoubi K.; Fores J.R.; Bertrand H.C.; Vincent A.; Tr\u00e9pout S.; Guerquin-Kern J.L.; Scheitler A.; Ivanovi\u0107-Burmazovi\u0107 I.; Seksik P.; Delsuc N.; Policar C.; Anti-inflammatory activity of superoxide dismutase mimics functionalized with cell-penetrating peptides. Dalton Trans 2020,49(7),2323-2330","journal-title":"Dalton Trans"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1161\/ATVBAHA.109.194738","volume":"29","author":"Wagner A.H.","year":"2009","unstructured":"Wagner A.H.; Kautz O.; Fricke K.; Zerr-Fouineau M.; Demicheva E.; G\u00fcldenzoph B.; Bermejo J.L.; Korff T.; Hecker M.; Upregulation of glutathione peroxidase offsets stretch-induced proatherogenic gene expression in human endothelial cells. Arterioscler Thromb Vasc Biol 2009,29(11),1894-1901","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.1161\/CIRCULATIONAHA.106.664250","volume":"115","author":"Lewis P.","year":"2007","unstructured":"Lewis P.; Stefanovic N.; Pete J.; Calkin A.C.; Giunti S.; Thallas-Bonke V.; Jandeleit-Dahm K.A.; Allen T.J.; Kola I.; Cooper M.E.; de Haan J.B.; Lack of the antioxidant enzyme glutathione peroxidase-1 accelerates atherosclerosis in diabetic apolipoprotein E-deficient mice. Circulation 2007,115(16),2178-2187","journal-title":"Circulation"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1161\/01.ATV.0000258809.47285.07","volume":"27","author":"Torzewski M.","year":"2007","unstructured":"Torzewski M.; Ochsenhirt V.; Kleschyov A.L.; Oelze M.; Daiber A.; Li H.; Rossmann H.; Tsimikas S.; Reifenberg K.; Cheng F.; Lehr H.A.; Blankenberg S.; F\u00f6rstermann U.; M\u00fcnzel T.; Lackner K.J.; Deficiency of glutathione peroxidase-1 accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 2007,27(4),850-857","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.bcp.2008.09.029","volume":"77","author":"Day B.J.","year":"2009","unstructured":"Day B.J.; Catalase and glutathione peroxidase mimics. Biochem Pharmacol 2009,77(3),285-296","journal-title":"Biochem Pharmacol"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.lfs.2015.05.004","volume":"134","author":"Ahwach S.M.","year":"2015","unstructured":"Ahwach S.M.; Thomas M.; Onstead-Haas L.; Mooradian A.D.; Haas M.J.; The glutathione mimic ebselen inhibits oxidative stress but not endoplasmic reticulum stress in endothelial cells. Life Sci 2015,134,9-15","journal-title":"Life Sci"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.ejphar.2003.11.079","volume":"485","author":"Ali N.","year":"2004","unstructured":"Ali N.; Yoshizumi M.; Tsuchiya K.; Kyaw M.; Fujita Y.; Izawa Y.; Abe S.; Kanematsu Y.; Kagami S.; Tamaki T.; Ebselen inhibits p38 mitogen-activated protein kinase-mediated endothelial cell death by hydrogen peroxide. Eur J Pharmacol 2004,485(1-3),127-135","journal-title":"Eur J Pharmacol"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1161\/01.RES.0000111802.09964.EF","volume":"94","author":"Brodsky S.V.","year":"2004","unstructured":"Brodsky S.V.; Gealekman O.; Chen J.; Zhang F.; Togashi N.; Crabtree M.; Gross S.S.; Nasjletti A.; Goligorsky M.S.; Prevention and reversal of premature endothelial cell senescence and vasculopathy in obesity-induced diabetes by ebselen. Circ Res 2004,94(3),377-384","journal-title":"Circ Res"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.vph.2015.11.001","volume":"79","author":"Sharma A.","year":"2016","unstructured":"Sharma A.; Yuen D.; Huet O.; Pickering R.; Stefanovic N.; Bernatchez P.; de Haan J.B.; Lack of glutathione peroxidase-1 facilitates a pro-inflammatory and activated vascular endothelium. Vascul Pharmacol 2016,79,32-42","journal-title":"Vascul Pharmacol"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"e72063","DOI":"10.1371\/journal.pone.0072063","volume":"8","author":"Cheng F.","year":"2013","unstructured":"Cheng F.; Torzewski M.; Degreif A.; Rossmann H.; Canisius A.; Lackner K.J.; Impact of glutathione peroxidase-1 deficiency on macrophage foam cell formation and proliferation: Implications for atherogenesis. PLoS One 2013,8(8),e72063","journal-title":"PLoS One"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"e69193","DOI":"10.1371\/journal.pone.0069193","volume":"8","author":"Tan S.M.","year":"2013","unstructured":"Tan S.M.; Sharma A.; Yuen D.Y.C.; Stefanovic N.; Krippner G.; Mugesh G.; Chai Z.; de Haan J.B.; The modified selenenyl amide, M-hydroxy ebselen, attenuates diabetic nephropathy and diabetes-associated atherosclerosis in ApoE\/GPx1 double knockout mice. PLoS One 2013,8(7),e69193","journal-title":"PLoS One"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1161\/ATVBAHA.109.186619","volume":"29","author":"Chew P.","year":"2009","unstructured":"Chew P.; Yuen D.Y.C.; Koh P.; Stefanovic N.; Febbraio M.A.; Kola I.; Cooper M.E.; de Haan J.B.; Site-specific antiatherogenic effect of the antioxidant ebselen in the diabetic apolipoprotein E-deficient mouse. Arterioscler Thromb Vasc Biol 2009,29(6),823-830","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"890","DOI":"10.3390\/antiox10060890","volume":"10","author":"Vermot A.","year":"2021","unstructured":"Vermot A.; Petit-H\u00e4rtlein I.; Smith S.M.E.; Fieschi F.; NADPH Oxidases (NOX): An overview from discovery, molecular mechanisms to physiology and pathology. Antioxidants 2021,10(6),890","journal-title":"Antioxidants"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"108453","DOI":"10.1016\/j.abb.2020.108453","volume":"689","author":"Peng R.","year":"2020","unstructured":"Peng R.; Luo M.; Tian R.; Lu N.; Dietary nitrate attenuated endothelial dysfunction and atherosclerosis in apolipoprotein E knockout mice fed a high-fat diet: A critical role for NADPH oxidase. Arch Biochem Biophys 2020,689,108453","journal-title":"Arch Biochem Biophys"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"165912","DOI":"10.1016\/j.bbadis.2020.165912","volume":"1866","author":"Yu W.","year":"2020","unstructured":"Yu W.; Xiao L.; Que Y.; Li S.; Chen L.; Hu P.; Xiong R.; Seta F.; Chen H.; Tong X.; Smooth muscle NADPH oxidase 4 promotes angiotensin II-induced aortic aneurysm and atherosclerosis by regulating osteopontin. Biochim Biophys Acta Mol Basis Dis 2020,1866(12),165912","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.3390\/ijms21041434","volume":"21","author":"Pejenaute \u00c1.","year":"2020","unstructured":"Pejenaute \u00c1.; Cort\u00e9s A.; Marqu\u00e9s J.; Montero L.; Beloqui \u00d3.; Fortu\u00f1o A.; Mart\u00ed A.; Orbe J.; Zalba G.; NADPH oxidase overactivity underlies telomere shortening in human atherosclerosis. Int J Mol Sci 2020,21(4),1434","journal-title":"Int J Mol Sci"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1111\/bph.13532","volume":"174","author":"Teixeira G.","year":"2017","unstructured":"Teixeira G.; Szyndralewiez C.; Molango S.; Carnesecchi S.; Heitz F.; Wiesel P.; Wood J.M.; Therapeutic potential of NADPH oxidase 1\/4 inhibitors. Br J Pharmacol 2017,174(12),1647-1669","journal-title":"Br J Pharmacol"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"26545","DOI":"10.1074\/jbc.M110.143917","volume":"285","author":"Vendrov A.E.","year":"2010","unstructured":"Vendrov A.E.; Madamanchi N.R.; Niu X.L.; Molnar K.C.; Runge M.; Szyndralewiez C.; Page P.; Runge M.S.; NADPH oxidases regulate CD44 and hyaluronic acid expression in thrombin-treated vascular smooth muscle cells and in atherosclerosis. J Biol Chem 2010,285(34),26545-26557","journal-title":"J Biol Chem"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"615","DOI":"10.3390\/nu13020615","volume":"13","author":"Dosed\u011bl M.","year":"2021","unstructured":"Dosed\u011bl M.; Jirkovsk\u00fd E.; Mac\u00e1kov\u00e1 K.; Kr\u010dmov\u00e1 L.; Javorsk\u00e1 L.; Pourov\u00e1 J.; Mercolini L.; Remi\u00e3o F.; Nov\u00e1kov\u00e1 L.; Mlad\u011bnka P.; Vitamin C\u2014sources, physiological role, kinetics, deficiency, use, toxicity, and determination. Nutrients 2021,13(2),615","journal-title":"Nutrients"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"817","DOI":"10.5551\/jat.2881","volume":"17","author":"Ray T.","year":"2010","unstructured":"Ray T.; Maity P.C.; Banerjee S.; Deb S.; Dasgupta A.K.; Sarkar S.; Sil A.K.; Vitamin C prevents cigarette smoke induced atherosclerosis in guinea pig model. J Atheroscler Thromb 2010,17(8),817-827","journal-title":"J Atheroscler Thromb"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1161\/01.CIR.103.14.1863","volume":"103","author":"Langlois M.","year":"2001","unstructured":"Langlois M.; Duprez D.; Delanghe J.; De Buyzere M.; Clement D.L.; Serum vitamin C concentration is low in peripheral arterial disease and is associated with inflammation and severity of atherosclerosis. Circulation 2001,103(14),1863-1868","journal-title":"Circulation"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1007\/s12603-020-1529-7","volume":"25","author":"Woo K.S.","year":"2021","unstructured":"Woo K.S.; Yip T.W.C.; Chook P.; Koon K.V.; Leong H.C.; Feng X.H.; Lee A.P.W.; Kwok T.C.Y.; Vitamins B-12 and C supplementation improves arterial reactivity and structure in passive smokers: Implication in prevention of smoking-related atherosclerosis. J Nutr Health Aging 2021,25(2),248-254","journal-title":"J Nutr Health Aging"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1093\/ajcn\/76.3.549","volume":"76","author":"Huang H.Y.","year":"2002","unstructured":"Huang H.Y.; Appel L.J.; Croft K.D.; Miller E.R.; Mori T.A.; Puddey I.B.; Effects of vitamin C and vitamin E on in vivo lipid peroxidation: Results of a randomized controlled trial. Am J Clin Nutr 2002,76(3),549-555","journal-title":"Am J Clin Nutr"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1046\/j.1365-2796.2000.00752.x","volume":"248","author":"Salonen J.T.","year":"2000","unstructured":"Salonen J.T.; Nyyss\u00f6nen K.; Salonen R.; Lakka H.M.; Kaikkonen J.; Porkkala-Sarataho E.; Voutilainen S.; Lakka T.A.; Rissanen T.; Leskinen L.; Tuomainen T.P.; Valkonen V.P.; Ristonmaa U.; Poulsen H.E.; Antioxidant Supplementation in Atherosclerosis Prevention (ASAP) study: A randomized trial of the effect of vitamins E and C on 3-year progression of carotid atherosclerosis. J Intern Med 2000,248(5),377-386","journal-title":"J Intern Med"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1093\/advances\/nmab019","volume":"12","author":"Traber M.G.","year":"2021","unstructured":"Traber M.G.; Vitamin E. Adv Nutr 2021,12(3),1047-1048","journal-title":"Adv Nutr"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.freeradbiomed.2021.11.027","volume":"178","author":"Violi F.","year":"2022","unstructured":"Violi F.; Nocella C.; Loffredo L.; Carnevale R.; Pignatelli P.; Interventional study with vitamin E in cardiovascular disease and meta-analysis. Free Radic Biol Med 2022,178,26-41","journal-title":"Free Radic Biol Med"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1093\/gerona\/gly195","volume":"74","author":"Corina A.","year":"2019","unstructured":"Corina A.; Rangel-Z\u00fa\u00f1iga O.A.; Jim\u00e9nez-Lucena R.; Alcal\u00e1-D\u00edaz J.F.; Quintana-Navarro G.; Yubero-Serrano E.M.; L\u00f3pez-Moreno J.; Delgado-Lista J.; Tinahones F.; Ordov\u00e1s J.M.; L\u00f3pez-Miranda J.; P\u00e9rez-Mart\u00ednez P.; Low intake of vitamin E accelerates cellular aging in patients with established cardiovascular disease: The cordioprev study. J Gerontol A Biol Sci Med Sci 2019,74(6),770-777","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"e0206315","DOI":"10.1371\/journal.pone.0206315","volume":"13","author":"Chai S.C.","year":"2018","unstructured":"Chai S.C.; Foley E.M.; Arjmandi B.H.; Anti-atherogenic properties of vitamin E, aspirin, and their combination. PLoS One 2018,13(10),e0206315","journal-title":"PLoS One"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1016\/S0140-6736(97)01234-8","volume":"349","author":"Rapola J.M.","year":"1997","unstructured":"Rapola J.M.; Virtamo J.; Ripatti S.; Huttunen J.K.; Albanes D.; Taylor P.R.; Heinonen O.P.; Randomised trial of \u03b1-tocopherol and \u03b2-carotene supplements on incidence of major coronary events in men with previous myocardial infarction. Lancet 1997,349(9067),1715-1720","journal-title":"Lancet"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/S0140-6736(99)07072-5","volume":"354","year":"1999","unstructured":"Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet 1999,354(9177),447-455","journal-title":"Lancet"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1056\/NEJM200001203420302","volume":"342","author":"Yusuf S.","year":"2000","unstructured":"Yusuf S.; Dagenais G.; Pogue J.; Bosch J.; Sleight P.; Vitamin E supplementation and cardiovascular events in high-risk patients. N Engl J Med 2000,342(3),154-160","journal-title":"N Engl J Med"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1161\/CIRCRESAHA.118.313409","volume":"123","author":"Huang J.","year":"2018","unstructured":"Huang J.; Weinstein S.J.; Yu K.; M\u00e4nnist\u00f6 S.; Albanes D.; Serum beta carotene and overall and cause-specific mortality. Circ Res 2018,123(12),1339-1349","journal-title":"Circ Res"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/j.numecd.2012.01.008","volume":"22","author":"Karppi J.","year":"2012","unstructured":"Karppi J.; Laukkanen J.A.; M\u00e4kikallio T.H.; Ronkainen K.; Kurl S.; Low \u03b2-carotene concentrations increase the risk of cardiovascular disease mortality among Finnish men with risk factors. Nutr Metab Cardiovasc Dis 2012,22(10),921-928","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/S0021-9150(00)00403-2","volume":"153","author":"D\u2019Odorico A.","year":"2000","unstructured":"D\u2019Odorico A.; Martines D.; Kiechl S.; Egger G.; Oberhollenzer F.; Bonvicini P.; Sturniolo G.C.; Naccarato R.; Willeit J.; High plasma levels of \u03b1- and \u03b2-carotene are associated with a lower risk of atherosclerosis. Atherosclerosis 2000,153(1),231-239","journal-title":"Atherosclerosis"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1024\/0300-9831\/a000024","volume":"80","author":"Muz\u00e1kov\u00e1 V.","year":"2010","unstructured":"Muz\u00e1kov\u00e1 V.; Kand\u2019\u00e1r R.; Meloun M.; Skalick\u00fd J.; Kr\u00e1lovec K.; Z\u00e1kov\u00e1 P.; Vojt\u00edsek P.; Inverse correlation between plasma beta-carotene and interleukin-6 in patients with advanced coronary artery disease. Int J Vitam Nutr Res 2010,80(6),369-377","journal-title":"Int J Vitam Nutr Res"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.3390\/nu12061625","volume":"12","author":"Harari A.","year":"2020","unstructured":"Harari A.; Melnikov N.; Kandel Kfir M.; Kamari Y.; Mahler L.; Ben-Amotz A.; Harats D.; Cohen H.; Shaish A.; Dietary \u03b2-carotene rescues vitamin A deficiency and inhibits atherogenesis in apolipoprotein E-deficient mice. Nutrients 2020,12(6),1625","journal-title":"Nutrients"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1194\/jlr.RA120001066","volume":"61","author":"Zhou F.","year":"2020","unstructured":"Zhou F.; Wu X.; Pinos I.; Abraham B.M.; Barrett T.J.; von Lintig J.; Fisher E.A.; Amengual J.; \u03b2-Carotene conversion to vitamin A delays atherosclerosis progression by decreasing hepatic lipid secretion in mice. J Lipid Res 2020,61(11),1491-1503","journal-title":"J Lipid Res"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1093\/jn\/nxaa143","volume":"150","author":"Amengual J.","year":"2020","unstructured":"Amengual J.; Coronel J.; Marques C.; Aradillas-Garc\u00eda C.; Morales J.M.V.; Andrade F.C.D.; Erdman J.W.; Teran-Garcia M.; \u03b2-carotene oxygenase 1 activity modulates circulating cholesterol concentrations in mice and humans. J Nutr 2020,150(8),2023-2030","journal-title":"J Nutr"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"105169","DOI":"10.1016\/j.phrs.2020.105169","volume":"166","author":"Shan R.","year":"2021","unstructured":"Shan R.; Liu N.; Yan Y.; Liu B.; Apoptosis, autophagy and atherosclerosis: Relationships and the role of Hsp27. Pharmacol Res 2021,166,105169","journal-title":"Pharmacol Res"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"106854","DOI":"10.1016\/j.vph.2021.106854","volume":"140","author":"Li B.","year":"2021","unstructured":"Li B.; Luo Y.R.; Zhang Q.; Fu S.H.; Chen Y.D.; Tian J.W.; Guo Y.; Sitagliptin, a dipeptidyl peptidase-4 inhibitor, attenuates apoptosis of vascular smooth muscle cells and reduces atherosclerosis in diabetic apolipoprotein E\u2013deficient mice. Vascul Pharmacol 2021,140,106854","journal-title":"Vascul Pharmacol"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1093\/cvr\/cvy007","volume":"114","author":"Grootaert M.O.J.","year":"2018","unstructured":"Grootaert M.O.J.; Moulis M.; Roth L.; Martinet W.; Vindis C.; Bennett M.R.; De Meyer G.R.Y.; Vascular smooth muscle cell death, autophagy and senescence in atherosclerosis. Cardiovasc Res 2018,114(4),622-634","journal-title":"Cardiovasc Res"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1161\/ATVBAHA.115.306931","volume":"36","author":"Babaev V.R.","year":"2016","unstructured":"Babaev V.R.; Ding L.; Zhang Y.; May J.M.; Lin P.C.; Fazio S.; Linton M.F.; Macrophage IKK\u03b1 deficiency suppresses Akt phosphorylation, reduces cell survival, and decreases early atherosclerosis. Arterioscler Thromb Vasc Biol 2016,36(4),598-607","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1161\/01.ATV.0000148548.47755.22","volume":"25","author":"Liu J.","year":"2005","unstructured":"Liu J.; Thewke D.P.; Su Y.R.; Linton M.F.; Fazio S.; Sinensky M.S.; Reduced macrophage apoptosis is associated with accelerated atherosclerosis in low-density lipoprotein receptor-null mice. Arterioscler Thromb Vasc Biol 2005,25(1),174-179","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"S382","DOI":"10.1194\/jlr.R800032-JLR200","volume":"50","author":"Seimon T.","year":"2009","unstructured":"Seimon T.; Tabas I.; Mechanisms and consequences of macrophage apoptosis in atherosclerosis. J Lipid Res 2009,50,S382-S387","journal-title":"J Lipid Res"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1161\/CIRCULATIONAHA.108.806158","volume":"119","author":"Gautier E.L.","year":"2009","unstructured":"Gautier E.L.; Huby T.; Witztum J.L.; Ouzilleau B.; Miller E.R.; Saint-Charles F.; Aucouturier P.; Chapman M.J.; Lesnik P.; Macrophage apoptosis exerts divergent effects on atherogenesis as a function of lesion stage. Circulation 2009,119(13),1795-1804","journal-title":"Circulation"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1038\/nri3520","volume":"13","author":"Moore K.J.","year":"2013","unstructured":"Moore K.J.; Sheedy F.J.; Fisher E.A.; Macrophages in atherosclerosis: A dynamic balance. Nat Rev Immunol 2013,13(10),709-721","journal-title":"Nat Rev Immunol"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.cjca.2016.12.010","volume":"33","author":"Gonzalez L.","year":"2017","unstructured":"Gonzalez L.; Trigatti B.L.; Macrophage apoptosis and necrotic core development in atherosclerosis: A rapidly advancing field with clinical relevance to imaging and therapy. Can J Cardiol 2017,33(3),303-312","journal-title":"Can J Cardiol"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1042\/BST20200522","volume":"49","author":"Dadsena S.","year":"2021","unstructured":"Dadsena S.; Zollo C.; Garc\u00eda-S\u00e1ez A.J.; Mechanisms of mitochondrial cell death. Biochem Soc Trans 2021,49(2),663-674","journal-title":"Biochem Soc Trans"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/s41580-019-0173-8","volume":"21","author":"Bock F.J.","year":"2020","unstructured":"Bock F.J.; Tait S.W.G.; Mitochondria as multifaceted regulators of cell death. Nat Rev Mol Cell Biol 2020,21(2),85-100","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.biochi.2017.02.001","volume":"135","author":"Shakeri R.","year":"2017","unstructured":"Shakeri R.; Kheirollahi A.; Davoodi J.; Apaf-1: Regulation and function in cell death. Biochimie 2017,135,111-125","journal-title":"Biochimie"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1111\/febs.13970","volume":"284","author":"Larsen B.D.","year":"2017","unstructured":"Larsen B.D.; S\u00f8rensen C.S.; The caspase-activated  ase: Apoptosis and beyond. FEBS J 2017,284(8),1160-1170","journal-title":"FEBS J"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.tcb.2017.01.003","volume":"27","author":"Zamaraev A.V.","year":"2017","unstructured":"Zamaraev A.V.; Kopeina G.S.; Prokhorova E.A.; Zhivotovsky B.; Lavrik I.N.; Post-translational modification of caspases: The other side of apoptosis regulation. Trends Cell Biol 2017,27(5),322-339","journal-title":"Trends Cell Biol"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"3209","DOI":"10.1242\/jcs.073643","volume":"123","author":"Bratton S.B.","year":"2010","unstructured":"Bratton S.B.; Salvesen G.S.; Regulation of the Apaf-1\u2013caspase-9 apoptosome. J Cell Sci 2010,123(19),3209-3214","journal-title":"J Cell Sci"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"105599","DOI":"10.1016\/j.phrs.2021.105599","volume":"168","author":"Duan H.","year":"2021","unstructured":"Duan H.; Zhang Q.; Liu J.; Li R.; Wang D.; Peng W.; Wu C.; Suppression of apoptosis in vascular endothelial cell, the promising way for natural medicines to treat atherosclerosis. Pharmacol Res 2021,168,105599","journal-title":"Pharmacol Res"},{"key":"ref=104","first-page":"1453","volume":"19","author":"Xia X.","year":"2019","unstructured":"Xia X.; Li J.; Liang X.; Zhang S.; Liu T.; Liu J.; Arif M.; Li G.; Ticagrelor suppresses oxidized low-density lipoprotein-induced endothelial cell apoptosis and alleviates atherosclerosis in ApoE-\/- mice via downregulation of PCSK9. Mol Med Rep 2019,19(3),1453-1462","journal-title":"Mol Med Rep"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.atherosclerosis.2019.04.202","volume":"285","author":"Yang S.","year":"2019","unstructured":"Yang S.; Zhang W.; Xuan L.; Han F.; Lv Y.; Wan Z.; Liu H.; Ren L.; Gong L.; Liu L.; Akebia Saponin D inhibits the formation of atherosclerosis in ApoE mice by attenuating oxidative stress-induced apoptosis in endothelial cells. Atherosclerosis 2019,285,23-30","journal-title":"Atherosclerosis"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"658998","DOI":"10.3389\/fphar.2021.658998","volume":"12","author":"Huang D.","year":"2021","unstructured":"Huang D.; Wang X.; Zhu Y.; Gong J.; Liang J.; Song Y.; Zhang Y.; Liu L.; Wei C.; Bazi bushen capsule alleviates post-menopausal atherosclerosis via GPER1-dependent anti-inflammatory and anti-apoptotic effects. Front Pharmacol 2021,12,658998","journal-title":"Front Pharmacol"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/112_2020_42","volume":"178","author":"Fatahian A.","year":"2020","unstructured":"Fatahian A.; Haftcheshmeh S.M.; Azhdari S.; Farshchi H.K.; Nikfar B.; Momtazi-Borojeni A.A.; Promising anti-atherosclerotic effect of berberine: Evidence from in vitro, in vivo, and clinical studies. Rev Physiol Biochem Pharmacol 2020,178,83-110","journal-title":"Rev Physiol Biochem Pharmacol"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"762673","DOI":"10.3389\/fmolb.2021.762673","volume":"8","author":"Xing L.","year":"2021","unstructured":"Xing L.; Zhou X.; Li A.H.; Li H.J.; He C.X.; Qin W.; Zhao D.; Li P.Q.; Zhu L.; Cao H.L.; Atheroprotective effects and molecular mechanism of berberine. Front Mol Biosci 2021,8,762673","journal-title":"Front Mol Biosci"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"118253","DOI":"10.1016\/j.lfs.2020.118253","volume":"259","author":"Wang L.","year":"2020","unstructured":"Wang L.; Deng L.; Lin N.; Shi Y.; Chen J.; Zhou Y.; Chen D.; Liu S.; Li C.; Berberine inhibits proliferation and apoptosis of vascular smooth muscle cells induced by mechanical stretch via the PDI\/ERS and MAPK pathways. Life Sci 2020,259,118253","journal-title":"Life Sci"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"118714","DOI":"10.1016\/j.lfs.2020.118714","volume":"264","author":"Liu Y.","year":"2021","unstructured":"Liu Y.; Song A.; Wu H.; Sun Y.; Dai M.; Paeonol inhibits apoptosis of vascular smooth muscle cells via up-regulation of autophagy by activating class III PI3K\/Beclin-1 signaling pathway. Life Sci 2021,264,118714","journal-title":"Life Sci"},{"key":"ref=111","first-page":"3302","volume":"24","author":"Wang Y.Q.","year":"2020","unstructured":"Wang Y.Q.; Xu Z.M.; Wang X.L.; Zheng J.K.; Du Q.; Yang J.X.; Zhang H.C.; LncRNA FOXC2-AS1 regulated proliferation and apoptosis of vascular smooth muscle cell through targeting miR-1253\/FOXF1 axis in atherosclerosis. Eur Rev Med Pharmacol Sci 2020,24(6),3302-3314","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1080\/21655979.2019.1705054","volume":"11","author":"Cheng Q.","year":"2020","unstructured":"Cheng Q.; Zhang M.; Zhang M.; Ning L.; Chen D.; Long non-coding RNA LOC285194 regulates vascular smooth muscle cell apoptosis in atherosclerosis. Bioengineered 2020,11(1),53-60","journal-title":"Bioengineered"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.atherosclerosis.2022.02.007","volume":"346","author":"Wang P.W.","year":"2022","unstructured":"Wang P.W.; Pang Q.; Zhou T.; Song X.Y.; Pan Y.J.; Jia L.P.; Zhang A.H.; Irisin alleviates vascular calcification by inhibiting VSMC osteoblastic transformation and mitochondria dysfunction via AMPK\/Drp1 signaling pathway in chronic kidney disease. Atherosclerosis 2022,346,36-45","journal-title":"Atherosclerosis"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"106072","DOI":"10.1016\/j.phrs.2022.106072","volume":"176","author":"Ajoolabady A.","year":"2022","unstructured":"Ajoolabady A.; Bi Y.; McClements D.J.; Lip G.Y.H.; Richardson D.R.; Reiter R.J.; Klionsky D.J.; Ren J.; Melatonin-based therapeutics for atherosclerotic lesions and beyond: Focusing on macrophage mitophagy. Pharmacol Res 2022,176,106072","journal-title":"Pharmacol Res"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/978-3-030-64872-5_5","volume":"1308","author":"Momtazi-Borojeni A.A.","year":"2021","unstructured":"Momtazi-Borojeni A.A.; Zabihi N.A.; Bagheri R.K.; Majeed M.; Jamialahmadi T.; Sahebkar A.; Intravenous curcumin mitigates atherosclerosis progression in cholesterol-fed rabbits. Adv Exp Med Biol 2021,1308,45-54","journal-title":"Adv Exp Med Biol"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"1520747","DOI":"10.1155\/2020\/1520747","volume":"2020","author":"Lin K.","year":"2020","unstructured":"Lin K.; Chen H.; Chen X.; Qian J.; Huang S.; Huang W.; Efficacy of curcumin on aortic atherosclerosis: A systematic review and meta-analysis in mouse studies and insights into possible mechanisms. Oxid Med Cell Longev 2020,2020,1520747","journal-title":"Oxid Med Cell Longev"},{"key":"ref=117","first-page":"1816","volume":"23","author":"Ouyang S.","year":"2019","unstructured":"Ouyang S.; Yao Y.H.; Zhang Z.M.; Liu J.S.; Xiang H.; Curcumin inhibits hypoxia inducible factor-1\u03b1-induced inflammation and apoptosis in macrophages through an ERK dependent pathway. Eur Rev Med Pharmacol Sci 2019,23(4),1816-1825","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/s41419-021-03712-w","volume":"12","author":"Ren J.L.","year":"2021","unstructured":"Ren J.L.; Chen Y.; Zhang L.S.; Zhang Y.R.; Liu S.M.; Yu Y.R.; Jia M.Z.; Tang C.S.; Qi Y.F.; Lu W.W.; Intermedin attenuates atherosclerotic plaque vulnerability by inhibiting CHOP-mediated apoptosis and inflammasome in macrophages. Cell Death Dis 2021,12(5),436","journal-title":"Cell Death Dis"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"9358","DOI":"10.7150\/thno.62797","volume":"11","author":"Fang S.","year":"2021","unstructured":"Fang S.; Sun S.; Cai H.; Zou X.; Wang S.; Hao X.; Wan X.; Tian J.; Li Z.; He Z.; Huang W.; Liang C.; Zhang Z.; Yang L.; Tian J.; Yu B.; Sun B.; IRGM\/Irgm1 facilitates macrophage apoptosis through ROS generation and MAPK signal transduction: Irgm1  mice display increases atherosclerotic plaque stability. Theranostics 2021,11(19),9358-9375","journal-title":"Theranostics"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1093\/cvr\/cvz138","volume":"116","author":"Galle-Treger L.","year":"2020","unstructured":"Galle-Treger L.; Moreau M.; Ballaire R.; Poupel L.; Huby T.; Sasso E.; Troise F.; Poti F.; Lesnik P.; Le Goff W.; Gautier E.L.; Huby T.; Targeted invalidation of SR-B1 in macrophages reduces macrophage apoptosis and accelerates atherosclerosis. Cardiovasc Res 2020,116(3),554-565","journal-title":"Cardiovasc Res"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1038\/nature08938","volume":"464","author":"Duewell P.","year":"2010","unstructured":"Duewell P.; Kono H.; Rayner K.J.; Sirois C.M.; Vladimer G.; Bauernfeind F.G.; Abela G.S.; Franchi L.; Nu\u00f1ez G.; Schnurr M.; Espevik T.; Lien E.; Fitzgerald K.A.; Rock K.L.; Moore K.J.; Wright S.D.; Hornung V.; Latz E.; NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature 2010,464(7293),1357-1361","journal-title":"Nature"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"507208","DOI":"10.1155\/2014\/507208","volume":"2014","author":"Zheng F.","year":"2014","unstructured":"Zheng F.; Xing S.; Gong Z.; Mu W.; Xing Q.; Silence of NLRP3 suppresses atherosclerosis and stabilizes plaques in apolipoprotein E-deficient mice. Mediators Inflamm 2014,2014,507208","journal-title":"Mediators Inflamm"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1038\/s41419-020-02985-x","volume":"11","author":"Bai B.","year":"2020","unstructured":"Bai B.; Yang Y.; Wang Q.; Li M.; Tian C.; Liu Y.; Aung L.H.H.; Li P.; Yu T.; Chu X.; NLRP3 inflammasome in endothelial dysfunction. Cell Death Dis 2020,11(9),776","journal-title":"Cell Death Dis"},{"key":"ref=124","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1016\/j.hlc.2013.01.012","volume":"22","author":"Zheng F.","year":"2013","unstructured":"Zheng F.; Xing S.; Gong Z.; Xing Q.; NLRP3 inflammasomes show high expression in aorta of patients with atherosclerosis. Heart Lung Circ 2013,22(9),746-750","journal-title":"Heart Lung Circ"},{"key":"ref=125","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1093\/eurheartj\/ehab107","volume":"42","author":"Schunk S.J.","year":"2021","unstructured":"Schunk S.J.; Kleber M.E.; M\u00e4rz W.; Pang S.; Zewinger S.; Triem S.; Ege P.; Reichert M.C.; Krawczyk M.; Weber S.N.; Jaumann I.; Schmit D.; Sarakpi T.; Wagenpfeil S.; Kramann R.; Boerwinkle E.; Ballantyne C.M.; Grove M.L.; Tragante V.; Pilbrow A.P.; Richards A.M.; Cameron V.A.; Doughty R.N.; Dub\u00e9 M.P.; Tardif J.C.; Feroz-Zada Y.; Sun M.; Liu C.; Ko Y.A.; Quyyumi A.A.; Hartiala J.A.; Tang W.H.W.; Hazen S.L.; Allayee H.; McDonough C.W.; Gong Y.; Cooper-DeHoff R.M.; Johnson J.A.; Scholz M.; Teren A.; Burkhardt R.; Martinsson A.; Smith J.G.; Wallentin L.; James S.K.; Eriksson N.; White H.; Held C.; Waterworth D.; Trompet S.; Jukema J.W.; Ford I.; Stott D.J.; Sattar N.; Cresci S.; Spertus J.A.; Campbell H.; Tierling S.; Walter J.; Ampofo E.; Niemeyer B.A.; Lipp P.; Schunkert H.; B\u00f6hm M.; Koenig W.; Fliser D.; Laufs U.; Speer T.; Genetically determined NLRP3 inflammasome activation associates with systemic inflammation and cardiovascular mortality. Eur Heart J 2021,42(18),1742-1756","journal-title":"Eur Heart J"},{"key":"ref=126","doi-asserted-by":"publisher","first-page":"eabl4024","DOI":"10.1126\/sciadv.abl4024","volume":"7","author":"Gu P.","year":"2021","unstructured":"Gu P.; Hui X.; Zheng Q.; Gao Y.; Jin L.; Jiang W.; Zhou C.; Liu T.; Huang Y.; Liu Q.; Nie T.; Wang Y.; Wang Y.; Zhao J.; Xu A.; Mitochondrial uncoupling protein 1 antagonizes atherosclerosis by blocking NLRP3 inflammasome\u2013dependent interleukin-1\u03b2 production. Sci Adv 2021,7(50),eabl4024","journal-title":"Sci Adv"},{"key":"ref=127","doi-asserted-by":"publisher","first-page":"7143","DOI":"10.2147\/JIR.S344730","volume":"14","author":"Jiang C.","year":"2021","unstructured":"Jiang C.; Xie S.; Yang G.; Wang N.; Spotlight on NLRP3 inflammasome: Role in pathogenesis and therapies of atherosclerosis. J Inflamm Res 2021,14,7143-7172","journal-title":"J Inflamm Res"},{"key":"ref=128","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1038\/s41423-021-00670-3","volume":"18","author":"Paik S.","year":"2021","unstructured":"Paik S.; Kim J.K.; Silwal P.; Sasakawa C.; Jo E.K.; An update on the regulatory mechanisms of NLRP3 inflammasome activation. Cell Mol Immunol 2021,18(5),1141-1160","journal-title":"Cell Mol Immunol"},{"key":"ref=129","doi-asserted-by":"publisher","first-page":"617","DOI":"10.3233\/JAD-2012-120145","volume":"30","author":"Mathew A.","year":"2012","unstructured":"Mathew A.; Lindsley T.A.; Sheridan A.; Bhoiwala D.L.; Hushmendy S.F.; Yager E.J.; Ruggiero E.A.; Crawford D.R.; Degraded mitochondrial DNA is a newly identified subtype of the damage associated molecular pattern (DAMP) family and possible trigger of neurodegeneration. J Alzheimers Dis 2012,30(3),617-627","journal-title":"J Alzheimers Dis"},{"key":"ref=130","doi-asserted-by":"publisher","first-page":"e1954","DOI":"10.1038\/cddis.2015.277","volume":"6","author":"Yaron J.R.","year":"2015","unstructured":"Yaron J.R.; Gangaraju S.; Rao M.Y.; Kong X.; Zhang L.; Su F.; Tian Y.; Glenn H.L.; Meldrum D.R.; K+ regulates Ca2+ to drive inflammasome signaling: Dynamic visualization of ion flux in live cells. Cell Death Dis 2015,6(10),e1954","journal-title":"Cell Death Dis"},{"key":"ref=131","doi-asserted-by":"publisher","first-page":"3937","DOI":"10.4049\/jimmunol.1402658","volume":"194","author":"Katsnelson M.A.","year":"2015","unstructured":"Katsnelson M.A.; Rucker L.G.; Russo H.M.; Dubyak G.R.; K+ efflux agonists induce NLRP3 inflammasome activation independently of Ca signaling. J Immunol 2015,194(8),3937-3952","journal-title":"J Immunol"},{"key":"ref=132","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1038\/ncomms2608","volume":"4","author":"Zhong Z.","year":"2013","unstructured":"Zhong Z.; Zhai Y.; Liang S.; Mori Y.; Han R.; Sutterwala F.S.; Qiao L.; TRPM2 links oxidative stress to NLRP3 inflammasome activation. Nat Commun 2013,4(1),1611","journal-title":"Nat Commun"},{"key":"ref=133","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/s41467-017-00227-x","volume":"8","author":"Tang T.","year":"2017","unstructured":"Tang T.; Lang X.; Xu C.; Wang X.; Gong T.; Yang Y.; Cui J.; Bai L.; Wang J.; Jiang W.; Zhou R.; CLICs-dependent chloride efflux is an essential and proximal upstream event for NLRP3 inflammasome activation. Nat Commun 2017,8(1),202","journal-title":"Nat Commun"},{"key":"ref=134","doi-asserted-by":"publisher","first-page":"2871","DOI":"10.1074\/jbc.M608083200","volume":"282","author":"Cruz C.M.","year":"2007","unstructured":"Cruz C.M.; Rinna A.; Forman H.J.; Ventura A.L.M.; Persechini P.M.; Ojcius D.M.; ATP activates a reactive oxygen species-dependent oxidative stress response and secretion of proinflammatory cytokines in macrophages. J Biol Chem 2007,282(5),2871-2879","journal-title":"J Biol Chem"},{"key":"ref=135","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/nature04516","volume":"440","author":"Martinon F.","year":"2006","unstructured":"Martinon F.; P\u00e9trilli V.; Mayor A.; Tardivel A.; Tschopp J.; Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 2006,440(7081),237-241","journal-title":"Nature"},{"key":"ref=136","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1002\/ehf2.13845","volume":"9","author":"Pappritz K.","year":"2022","unstructured":"Pappritz K.; Lin J.; El-Shafeey M.; Fechner H.; K\u00fchl U.; Alogna A.; Spillmann F.; Elsanhoury A.; Schulz R.; Tsch\u00f6pe C.; Van Linthout S.; Colchicine prevents disease progression in viral myocarditis via modulating the NLRP3 inflammasome in the cardiosplenic axis. ESC Heart Fail 2022,9(2),925-941","journal-title":"ESC Heart Fail"},{"key":"ref=137","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1042\/CS20160090","volume":"130","author":"Robertson S.","year":"2016","unstructured":"Robertson S.; Mart\u00ednez G.J.; Payet C.A.; Barraclough J.Y.; Celermajer D.S.; Bursill C.; Patel S.; Colchicine therapy in acute coronary syndrome patients acts on caspase-1 to suppress NLRP3 inflammasome monocyte activation. Clin Sci 2016,130(14),1237-1246","journal-title":"Clin Sci"},{"key":"ref=138","doi-asserted-by":"publisher","first-page":"8087","DOI":"10.1111\/jcmm.16798","volume":"25","author":"Li Y.","year":"2021","unstructured":"Li Y.; Zhang Y.; Lu J.; Yin Y.; Xie J.; Xu B.; Anti-inflammatory mechanisms and research progress of colchicine in atherosclerotic therapy. J Cell Mol Med 2021,25(17),8087-8094","journal-title":"J Cell Mol Med"},{"key":"ref=139","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.jacc.2012.10.027","volume":"61","author":"Nidorf S.M.","year":"2013","unstructured":"Nidorf S.M.; Eikelboom J.W.; Budgeon C.A.; Thompson P.L.; Low-dose colchicine for secondary prevention of cardiovascular disease. J Am Coll Cardiol 2013,61(4),404-410","journal-title":"J Am Coll Cardiol"},{"key":"ref=140","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/j.cjca.2020.10.006","volume":"37","author":"Samuel M.","year":"2021","unstructured":"Samuel M.; Tardif J.C.; Bouabdallaoui N.; Khairy P.; Dub\u00e9 M.P.; Blondeau L.; Guertin M.C.; Colchicine for secondary prevention of cardiovascular disease: A systematic review and meta-analysis of randomized controlled trials. Can J Cardiol 2021,37(5),776-785","journal-title":"Can J Cardiol"},{"key":"ref=141","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.1161\/CIRCULATIONAHA.120.050771","volume":"142","author":"Tong D.C.","year":"2020","unstructured":"Tong D.C.; Quinn S.; Nasis A.; Hiew C.; Roberts-Thomson P.; Adams H.; Sriamareswaran R.; Htun N.M.; Wilson W.; Stub D.; van Gaal W.; Howes L.; Collins N.; Yong A.; Bhindi R.; Whitbourn R.; Lee A.; Hengel C.; Asrress K.; Freeman M.; Amerena J.; Wilson A.; Layland J.; Colchicine in patients with acute coronary syndrome. Circulation 2020,142(20),1890-1900","journal-title":"Circulation"},{"key":"ref=142","doi-asserted-by":"publisher","first-page":"e020377","DOI":"10.1161\/JAHA.120.020377","volume":"10","author":"Ambrosy A.P.","year":"2021","unstructured":"Ambrosy A.P.; Yang J.; Sung S.H.; Allen A.R.; Fitzpatrick J.K.; Rana J.S.; Wagner J.; Philip S.; Abrahamson D.; Granowitz C.; Go A.S.; Triglyceride levels and residual risk of atherosclerotic cardiovascular disease events and death in adults receiving statin therapy for primary or secondary prevention: Insights from the Kp reach study. J Am Heart Assoc 2021,10(20),e020377","journal-title":"J Am Heart Assoc"},{"key":"ref=143","doi-asserted-by":"publisher","first-page":"e007183","DOI":"10.1161\/CIRCOUTCOMES.120.007183","volume":"14","author":"Pavlovi\u0107 J.","year":"2021","unstructured":"Pavlovi\u0107 J.; Greenland P.; Franco O.H.; Kavousi M.; Ikram M.K.; Deckers J.W.; Ikram M.A.; Leening M.J.G.; Recommendations and Associated Levels of Evidence for Statin Use in Primary Prevention of Cardiovascular Disease: A Comparison at Population Level of the American Heart Association\/American College of Cardiology\/Multisociety, US Preventive Services Task Force, Department of Veterans Affairs\/Department of Defense, Canadian Cardiovascular Society, and European Society of Cardiology\/European Atherosclerosis Society Clinical Practice Guidelines. Circ Cardiovasc Qual Outcomes 2021,14(9),e007183","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"ref=144","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s12016-020-08791-9","volume":"60","author":"Koushki K.","year":"2021","unstructured":"Koushki K.; Shahbaz S.K.; Mashayekhi K.; Sadeghi M.; Zayeri Z.D.; Taba M.Y.; Banach M.; Al-Rasadi K.; Johnston T.P.; Sahebkar A.; Anti-inflammatory action of statins in cardiovascular disease: The role of inflammasome and toll-like receptor pathways. Clin Rev Allergy Immunol 2021,60(2),175-199","journal-title":"Clin Rev Allergy Immunol"},{"key":"ref=145","doi-asserted-by":"publisher","first-page":"438","DOI":"10.3389\/fphar.2018.00438","volume":"9","author":"Peng S.","year":"2018","unstructured":"Peng S.; Xu L.W.; Che X.Y.; Xiao Q.Q.; Pu J.; Shao Q.; He B.; Atorvastatin inhibits inflammatory response, attenuates lipid deposition, and improves the stability of vulnerable atherosclerotic plaques by modulating autophagy. Front Pharmacol 2018,9,438","journal-title":"Front Pharmacol"},{"key":"ref=146","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/s41419-021-03389-1","volume":"12","author":"Chen A.","year":"2021","unstructured":"Chen A.; Chen Z.; Zhou Y.; Wu Y.; Xia Y.; Lu D.; Fan M.; Li S.; Chen J.; Sun A.; Zou Y.; Qian J.; Ge J.; Rosuvastatin protects against coronary microembolization-induced cardiac injury via inhibiting NLRP3 inflammasome activation. Cell Death Dis 2021,12(1),78","journal-title":"Cell Death Dis"},{"key":"ref=147","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1042\/CS20130043","volume":"126","author":"Satoh M.","year":"2014","unstructured":"Satoh M.; Tabuchi T.; Itoh T.; Nakamura M.; NLRP3 inflammasome activation in coronary artery disease: Results from prospective and randomized study of treatment with atorvastatin or rosuvastatin. Clin Sci 2014,126(3),233-241","journal-title":"Clin Sci"},{"key":"ref=148","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.intimp.2019.05.006","volume":"73","author":"Parsamanesh N.","year":"2019","unstructured":"Parsamanesh N.; Moossavi M.; Bahrami A.; Fereidouni M.; Barreto G.; Sahebkar A.; NLRP3 inflammasome as a treatment target in atherosclerosis: A focus on statin therapy. Int Immunopharmacol 2019,73,146-155","journal-title":"Int Immunopharmacol"},{"key":"ref=149","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/s41589-019-0277-7","volume":"15","author":"Coll R.C.","year":"2019","unstructured":"Coll R.C.; Hill J.R.; Day C.J.; Zamoshnikova A.; Boucher D.; Massey N.L.; Chitty J.L.; Fraser J.A.; Jennings M.P.; Robertson A.A.B.; Schroder K.; MCC950 directly targets the NLRP3 ATP-hydrolysis motif for inflammasome inhibition. Nat Chem Biol 2019,15(6),556-559","journal-title":"Nat Chem Biol"},{"key":"ref=150","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s10753-019-01098-8","volume":"43","author":"Wu D.","year":"2020","unstructured":"Wu D.; Chen Y.; Sun Y.; Gao Q.; Li H.; Yang Z.; Wang Y.; Jiang X.; Yu B.; Target of MCC950 in inhibition of NLRP3 inflammasome activation: A literature review. Inflammation 2020,43(1),17-23","journal-title":"Inflammation"},{"key":"ref=151","doi-asserted-by":"publisher","first-page":"772","DOI":"10.2337\/db20-0357","volume":"70","author":"Sharma A.","year":"2021","unstructured":"Sharma A.; Choi J.S.Y.; Stefanovic N.; Al-Sharea A.; Simpson D.S.; Mukhamedova N.; Jandeleit-Dahm K.; Murphy A.J.; Sviridov D.; Vince J.E.; Ritchie R.H.; de Haan J.B.; Specific NLRP3 inhibition protects against diabetes-associated atherosclerosis. Diabetes 2021,70(3),772-787","journal-title":"Diabetes"},{"key":"ref=152","doi-asserted-by":"publisher","first-page":"19305","DOI":"10.1038\/s41598-021-98437-3","volume":"11","author":"Zeng W.","year":"2021","unstructured":"Zeng W.; Wu D.; Sun Y.; Suo Y.; Yu Q.; Zeng M.; Gao Q.; Yu B.; Jiang X.; Wang Y.; The selective NLRP3 inhibitor MCC950 hinders atherosclerosis development by attenuating inflammation and pyroptosis in macrophages. Sci Rep 2021,11(1),19305","journal-title":"Sci Rep"},{"key":"ref=153","doi-asserted-by":"publisher","first-page":"e8689","DOI":"10.15252\/emmm.201708689","volume":"10","author":"Huang Y.","year":"2018","unstructured":"Huang Y.; Jiang H.; Chen Y.; Wang X.; Yang Y.; Tao J.; Deng X.; Liang G.; Zhang H.; Jiang W.; Zhou R.; Tranilast directly targets  3 to treat inflammasome-driven diseases. EMBO Mol Med 2018,10(4),e8689","journal-title":"EMBO Mol Med"},{"key":"ref=154","doi-asserted-by":"publisher","first-page":"e015513","DOI":"10.1161\/JAHA.119.015513","volume":"9","author":"Chen S.","year":"2020","unstructured":"Chen S.; Wang Y.; Pan Y.; Liu Y.; Zheng S.; Ding K.; Mu K.; Yuan Y.; Li Z.; Song H.; Jin Y.; Fu J.; Novel role for tranilast in regulating NLRP3 ubiquitination, vascular inflammation, and atherosclerosis. J Am Heart Assoc 2020,9(12),e015513","journal-title":"J Am Heart Assoc"},{"key":"ref=155","doi-asserted-by":"publisher","first-page":"1479164120977441","DOI":"10.1177\/1479164120977441","volume":"17","author":"Zhao J.","year":"2020","unstructured":"Zhao J.; Wang Z.; Yuan Z.; Lv S.; Su Q.; Baicalin ameliorates atherosclerosis by inhibiting NLRP3 inflammasome in apolipoprotein E-deficient mice. Diab Vasc Dis Res 2020,17(6),1479164120977441","journal-title":"Diab Vasc Dis Res"},{"key":"ref=156","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1096\/fj.201900903RRR","volume":"34","author":"Luo J.","year":"2020","unstructured":"Luo J.; Wang X.; Jiang X.; Liu C.; Li Y.; Han X.; Zuo X.; Li Y.; Li N.; Xu Y.; Si S.; Rutaecarpine derivative R3 attenuates atherosclerosis via inhibiting NLRP3 inflammasome related inflammation and modulating cholesterol transport. FASEB J 2020,34(1),1398-1411","journal-title":"FASEB J"},{"key":"ref=157","doi-asserted-by":"publisher","first-page":"910","DOI":"10.18632\/aging.202202","volume":"13","author":"Wen J.","year":"2021","unstructured":"Wen J.; Chang Y.; Huo S.; Li W.; Huang H.; Gao Y.; Lin H.; Zhang J.; Zhang Y.; Zuo Y.; Cao X.; Zhong F.; Tanshinone IIA attenuates atherosclerosis via inhibiting NLRP3 inflammasome activation. Aging (Albany NY) 2021,13(1),910-932","journal-title":"Aging (Albany NY)"},{"key":"ref=158","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1039\/D0AY02294B","volume":"13","author":"Guo D.","year":"2021","unstructured":"Guo D.; Sun J.; Tian M.; Lin W.; Fabrication of a fluorescent probe for reversibly monitoring mitochondrial membrane potential in living cells. Anal Methods 2021,13(14),1715-1719","journal-title":"Anal Methods"},{"key":"ref=159","doi-asserted-by":"publisher","first-page":"4009","DOI":"10.1021\/acssensors.1c01390","volume":"6","author":"Lin B.","year":"2021","unstructured":"Lin B.; Liu Y.; Zhang X.; Fan L.; Shu Y.; Wang J.; Membrane-activated fluorescent probe for high-fidelity imaging of mitochondrial membrane potential. ACS Sens 2021,6(11),4009-4018","journal-title":"ACS Sens"},{"key":"ref=160","doi-asserted-by":"publisher","first-page":"5195","DOI":"10.3390\/ijms20205195","volume":"20","author":"Su\u00e1rez-Rivero J.M.","year":"2019","unstructured":"Su\u00e1rez-Rivero J.M.; Pastor-Maldonado C.J.; de la Mata M.; Villanueva-Paz M.; Povea-Cabello S.; \u00c1lvarez-C\u00f3rdoba M.; Villal\u00f3n-Garc\u00eda I.; Su\u00e1rez-Carrillo A.; Talaver\u00f3n-Rey M.; Munuera M.; S\u00e1nchez-Alc\u00e1zar J.A.; Atherosclerosis and coenzyme Q. Int J Mol Sci 2019,20(20),5195","journal-title":"Int J Mol Sci"},{"key":"ref=161","doi-asserted-by":"publisher","first-page":"e0185688","DOI":"10.1371\/journal.pone.0185688","volume":"12","author":"Zhang M.","year":"2017","unstructured":"Zhang M.; Zhao H.; Cai J.; Li H.; Wu Q.; Qiao T.; Li K.; Chronic administration of mitochondrion-targeted peptide SS-31 prevents atherosclerotic development in ApoE knockout mice fed Western diet. PLoS One 2017,12(9),e0185688","journal-title":"PLoS One"},{"key":"ref=162","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/nrd4023","volume":"12","author":"Andreux P.A.","year":"2013","unstructured":"Andreux P.A.; Houtkooper R.H.; Auwerx J.; Pharmacological approaches to restore mitochondrial function. Nat Rev Drug Discov 2013,12(6),465-483","journal-title":"Nat Rev Drug Discov"},{"key":"ref=163","doi-asserted-by":"publisher","first-page":"4892","DOI":"10.1111\/jcmm.15194","volume":"24","author":"Popov L.D.","year":"2020","unstructured":"Popov L.D.; Mitochondrial biogenesis: An update. J Cell Mol Med 2020,24(9),4892-4899","journal-title":"J Cell Mol Med"},{"key":"ref=164","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.biochi.2022.01.002","volume":"195","author":"Ulger O.","year":"2022","unstructured":"Ulger O.; Kubat G.B.; Therapeutic applications of mitochondrial transplantation. Biochimie 2022,195,1-15","journal-title":"Biochimie"}],"container-title":["Current Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0929867330666221201120405","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/211485\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0929867330666221201120405","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,2]],"date-time":"2023-09-02T20:03:38Z","timestamp":1693685018000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/211485\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":164,"journal-issue":{"issue":"38","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0929867330666221201120405","relation":{},"ISSN":["0929-8673"],"issn-type":[{"value":"0929-8673","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-08-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-09-27","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-10-14","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-06-15","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}